Blog

6 February 2026

Sagimet and Ascletis Reveal Promising Long-Term Data for Denifanstat in Acne

Discover Sagimet and Ascletis's latest 52-week data on denifanstat, a groundbreaking treatment for moderate to severe acne. Learn about its...
Read more
Sagimet and Ascletis Reveal Promising Long-Term Data for Denifanstat in Acne
New Trial Launches to Explore Polyamine Inhibition in Cancer Treatment

New Trial Launches to Explore Polyamine Inhibition in Cancer Treatment

Discover how Aminex Therapeutics' new trial tests AMXT 1501 and DFMO in treating metastatic melanoma and advanced breast cancer. Explore...
5 02 2026
Read more
AbbVie Seeks Approval for Upadacitinib as First Systemic Vitiligo Treatment

AbbVie Seeks Approval for Upadacitinib as First Systemic Vitiligo Treatment

Discover how AbbVie is pioneering the treatment of non-segmental vitiligo with upadacitinib, aiming for FDA and EMA approval as the...
4 02 2026
Read more
Seysara Approved in China: A New Hope for Moderate to Severe Acne

Seysara Approved in China: A New Hope for Moderate to Severe Acne

Discover how Seysara's recent approval in China offers new hope for patients with moderate to severe acne. Learn about its...
4 02 2026
Read more
Evaluating 1-Year Efficacy of Biologics for Hidradenitis Suppurativa

Evaluating 1-Year Efficacy of Biologics for Hidradenitis Suppurativa

Discover the 1-year efficacy of biologics for treating hidradenitis suppurativa, exploring their impact on inflammation, comorbidities, and long-term outcomes.
3 02 2026
Read more
Effective Fractional CO₂ Resurfacing for Acne Scars in Darker Skin Types

Effective Fractional CO₂ Resurfacing for Acne Scars in Darker Skin Types

Discover effective fractional CO₂ resurfacing for acne scars in darker skin types. Learn safe, innovative treatments to boost self-esteem and...
3 02 2026
Read more
Revolutionary Treatments for Chronic Eczema, Urticaria, and Vitiligo in 2026

Revolutionary Treatments for Chronic Eczema, Urticaria, and Vitiligo in 2026

Discover groundbreaking treatments for chronic eczema, urticaria, and vitiligo in 2026 that are transforming patient care and enhancing quality of...
2 02 2026
Read more
Phase 2 Trial Highlights Soficitinib’s Potential in Treating Atopic Dermatitis

Phase 2 Trial Highlights Soficitinib’s Potential in Treating Atopic Dermatitis

Discover the promising results of a Phase 2 trial highlighting soficitinib's potential in treating moderate to severe atopic dermatitis. Learn...
2 02 2026
Read more
Integrative Medicine: Transforming Aesthetic Dermatology for Better Skin Health

Integrative Medicine: Transforming Aesthetic Dermatology for Better Skin Health

Discover how integrative medicine is revolutionizing aesthetic dermatology by promoting holistic skin health. Learn about the inside-out approach for better...
2 02 2026
Read more